(Q36819965)

English

Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience

scientific article published on May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

0 references

0 references

author name string

J Schneiderman

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

E Rubin

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

D J Nugent

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

G Young

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

244-248

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

The hemophilias--from royal genes to gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

New approaches in the management of inhibitor patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01451.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2007.01451.X

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36819965&oldid=1657856511"